Q4 Financial Statement: Talis Biomedical Corp. (TLIS) Stock Plunged Deep in Early Trades.
Maria Masood
March 16, 2022
Talis Biomedical Corp. (TLIS) delivers precise infectious disease testing as it is devoted to progressing health equity and outcomes. The company plans the production and